ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CLNN vs HOWL // RETURN ON INVESTED CAPITAL (ROIC)

Clene Inc. (NASDAQ) VS. Werewolf Therapeutics Inc. (NASDAQ) • 15-METRIC TALLY: CLNN 1 — HOWL 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CLNN VS. HOWL) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CLNN HOWL SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 78.50% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) ACTIVE -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% — — TIE /operating-margins <GO>
Net Profit Margin -60.00% — — TIE /net-margins <GO>
Revenue Growth (YoY) -41.50% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 3/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 42.8 57.9 -15.10 HOWL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $51.3M $51.0M $283.5K CLNN /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CLNN REV HOWL REV CLNN GROSS % HOWL GROSS % CLNN FCF HOWL FCF
FY 2025 $200.0K $169.9M 78.5% — -$18.6M -$60.3M
FY 2024 $342.0K $206.1M 79.5% — -$21.3M -$56.4M
FY 2023 $654.0K $113.4M — — -$30.2M -$32.6M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CLNN // BETA —
HOWL // BETA —